Boundless Bio Inc. (BOLD)
NASDAQ: BOLD
· Real-Time Price · USD
1.16
-0.01 (-0.85%)
At close: Aug 15, 2025, 3:59 PM
1.16
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT
Boundless Bio Income Statement
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
Revenue | n/a | n/a | 1.06M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 317K | 317K | 296K | 262K | 265K | 263K | 247K | 235K | n/a | 237K | 239K | 246K |
Gross Profit | -317K | -317K | 528K | -262K | -265K | -263K | -247K | -235K | n/a | -237K | -239K | -246K |
Operating Income | -17.06M | -17.34M | -18.28M | -18.71M | -19.39M | -16.88M | -13.8M | -14.95M | -13.96M | -12.09M | -12.07M | -13.25M |
Interest Income | 1.39M | 1.58M | 1.92M | 2.17M | 2.38M | 1.42M | 1.62M | 1.71M | 1.56M | 395K | 297K | 224K |
Pretax Income | -15.68M | -15.76M | -16.45M | -16.51M | -16.98M | -15.43M | -12.14M | -13.17M | -12.4M | -11.72M | -11.78M | -13.13M |
Net Income | -15.68M | -15.76M | -16.45M | -16.51M | -16.98M | -15.43M | -12.14M | -13.17M | -12.4M | -11.72M | -11.78M | -13.13M |
Selling & General & Admin | 4.84M | 5.2M | 4.96M | 4.63M | 4.66M | 3.75M | 3.38M | 3.31M | 2.89M | 2.58M | 2.42M | 2.5M |
Research & Development | 11.9M | 12.14M | 13.31M | 14.09M | 14.47M | 12.87M | 10.41M | 11.65M | 11.07M | 9.27M | 9.66M | 10.51M |
Other Expenses | n/a | -317K | -296K | n/a | n/a | 32K | 32K | 75K | 11K | -27K | -3K | n/a |
Operating Expenses | 16.74M | 17.02M | 17.98M | 18.71M | 19.13M | 16.62M | 13.8M | 14.95M | 13.96M | 11.85M | 12.07M | 13.01M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 17.06M | 17.34M | 18.28M | 18.71M | 19.39M | 16.88M | 13.8M | 14.95M | 13.96M | 12.09M | 12.07M | 13.25M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 115.92K | n/a | n/a | n/a |
Shares Outstanding (Basic) | 22.36M | 22.3M | 16.98M | 22.25M | 22.02M | 22.24M | 22.24M | 22.24M | 22.24M | 22.24M | 22.24M | 22.24M |
Shares Outstanding (Diluted) | 22.36M | 22.3M | 16.98M | 22.25M | 22.02M | 22.24M | 22.24M | 22.24M | 22.24M | 22.24M | 22.24M | 22.24M |
EPS (Basic) | -0.7 | -0.71 | -0.84 | -0.74 | -0.77 | -0.69 | -0.55 | -0.59 | -0.56 | -0.53 | -0.53 | -0.59 |
EPS (Diluted) | -0.7 | -0.71 | -0.84 | -0.74 | -0.77 | -0.69 | -0.55 | -0.59 | -0.56 | -0.53 | -0.53 | -0.59 |
EBITDA | -15.36M | -17.34M | -10.08M | -18.45M | -19.13M | -16.62M | -13.55M | -14.72M | -13.72M | -11.85M | -11.83M | -13.01M |
EBIT | -15.68M | -15.76M | -10.37M | -18.71M | -19.39M | -16.88M | -13.8M | -14.95M | -13.96M | -12.09M | -12.07M | -13.25M |
Depreciation & Amortization | 317K | 317K | 296K | 262K | 265K | 263K | 247K | 235K | 238K | 237K | 239K | 246K |